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Abstract: Oxidative stress induced by the oxidative pathway dysregulation following ischemia/reperfusion has 
been proposed as an important cause of neuronal death and brain damage. The proteins of the thioredoxin (Trx) 
family are crucial mediators of protein function regulating the intracellular hydrogen peroxide levels and redox-
sensitive post-translational protein changes. This study evaluates the long-term effects of common carotid artery 
ligation-induced ischemia/reperfusion on the protein expression and distribution of fourteen members of the Trx 
family and related proteins (Grx1, Grx2, Grx3, Grx5, Prx1, Prx2, Prx3, Prx4, Prx5, Prx6, Trx1, Trx2, TrxR1, 
TrxR2) in the most hypoxia susceptible rat brain areas, namely, cerebellum, corpus striatum, and the hippocam-
pus. The thioredoxin proteins displayed a complex, cell-type, and tissue-specific expression pattern following 
ischemia/reperfusion. Even 60 days after ischemia/reperfusion, Western blot analysis showed a persistent expres-
sion of Trx1 and Grx2 in several brain areas. Thioredoxins might participate in the long-term restoration of redox 
signaling, and the recovery of the affected tissues. 
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1. INTRODUCTION 
 Brain damage resulting from an ischemic event in the fetus or 
newborn infant (also known as perinatal asphyxia, PA) remains a 
major cause of neonatal death and neurological deficits in children. 
Cerebral palsy, mental retardation, and epilepsy are among the most 
common complications of perinatal asphyxia [1-4]. The incidence 
of severe perinatal asphyxia is estimated to about 1:1000 live births 
in developed countries, and 5-10:1000 live births in developing 
countries [5]. This clinical picture has been largely reproduced, 
exposing rodents to an oxygen-deprived atmosphere on post-natal 
day seven after the right common carotid artery (CCA) ligation [3, 
6-9]. By post-natal day seven, the rat brain is histologically similar 
to that of a 32-34 week gestation human fetus or a newborn infant, 
e.g., the cerebrocortical neuronal layering is complete, the germinal 
matrix shows involution, and the white matter has undergone little 
myelination [10]. 
 Reactive oxygen species (ROS) are a likely cause of neuronal 
death and brain damage after ischemia/reperfusion [11]. Aerobic 
metabolism renders oxygen free radicals in the cytoplasm and mito-
chondria [12], physiologically involved in specific signalling proc-
esses such as developmental regulation, cell proliferation, differen-
tiation, and apoptosis. Locally produced, and swiftly degraded by 
specific enzymes, ROS interact with specific target molecules [12]. 
However, excessive production of ROS can lead to oxidative and 
irreversible damage to macromolecules and has been linked to vari-
ous pathological conditions like ischemia-reperfusion [11, 13, 14]. 
 Several therapeutic approaches have been proposed to neutral-
ize ischemia-induced ROS like the administration of degrading  
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substances to reduce their chemical reactivity, free radical inhibi-
tors, and scavengers [5]. However, no neuroprotective agent has 
been proved safe and effective in protecting ischemic-insult neo-
nates from neurological sequels. It urges deepening our insight into 
biochemical and cellular mechanisms of neuronal injury induced by 
perinatal asphyxia to identify potential therapeutic targets and com-
pounds [15]. 
 Thioredoxin (Trx) family members are small proteins typically 
bearing the unique Trx folding and the cysteine-containing active 
site motif, crucial for electron transfer and oxidoreductase activity 
[16, 17]. Thioredoxins and glutaredoxins (Grx) were first identified 
as electron donors to ribonucleotide reductase, and later described 
as cellular antioxidants protecting cells from reactive oxygen spe-
cies-induced cell death. Peroxiredoxins (Prx), involved in peroxide 
decomposition, were identified as one of the major cellular peroxi-
dases [16]. Currently, the thioredoxin family is recognized as com-
prising regulatory proteins crucially affecting protein function 
through oxidative post-translational changes or involved in the local 
and specific hydrogen peroxide degradation [17]. 
 This study analyzes the expression and distribution of fourteen 
members of the Trx family, potentially essential for the regenera-
tion upon long-term brain damage, in a perinatal hypoxia-ischemia 
rat model induced by a common carotid artery ligation. 
2. MATERIALS AND METHODS 
2.1. Animals 
 Pregnant Sprague-Dawley rats from the central bioterium of the 
School of Veterinary Sciences of the University of Buenos Aires 
were kept in a controlled environment at 21 ± 2 °C and 65 ± 5% 
humidity on a 12h light-dark cycle (lights on at 8 a.m.) with free 
access to Purina chow food and tap water. The experiments were 
conducted according to the principles of the Guide for the Care and 
Use of Laboratory Animals (NIH Publications No. 80-23, revised 
1996), and approved by the Institutional Animal Care and Use 
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Committee at the School of Medicine of the University of Buenos 
Aires. All efforts were made to reduce the number of animals used 
and minimize suffering. 
2.2. Common Carotid Artery Ligation Procedure 
 On day seven after birth (P7), male offsprings were i.p. anesthe-
tized with ketamine 40 mg/kg-xylazine 4 mg/kg, and placed on a 
heat plate to keep body temperature constant at 37 °C. The right 
common carotid artery (CCA) was exposed by an incision on the 
right side of the neck, isolated from nerve and vein, and perma-
nently ligated with 6-0 surgical silk (Carotid group). After wound 
suture, the animals were placed back to their cages for 4-5 h. After 
recovery, the pups were placed in a stoppered 1L glass jar partially 
submerged in a 37 °C water bath for thermal constancy, and ex-
posed to 100 % N2 (3L/min N2 flow) for 3 min to induce anoxia. 
Sham-surgery rats (Sham) underwent right CCA surgical exposure 
only but no ligation or N2 exposure. Euthanasia was administered to 
all rats at 30, 60, and 90 days of age. 
2.3. Western Blotting and Enzyme-linked Immunosorbent As-
say (ELISA) 
 The expression pattern of fourteen Trx proteins was analyzed in 
the cerebellum, corpus striatum, and hippocampus using Western 
blot or in the case of Grx2 by ELISA. 
 Western blot analysis was performed slightly modified from 
Godoy et al. (2011). Rat brains dissected after euthanasia by de-
capitation were homogenized in ice-cold cell lysis buffer (10 mM 
Tris/HCl, pH 7.4, 10 mM NaCl, 3 mM MgCl2, 0.1% NP-40 non-
ionic detergent), fast-frozen in liquid nitrogen and kept at -20 °C. 
For analysis, the samples were thawed on ice and centrifuged at 
13,500 x g for 20 min at 4 °C. After discarding the pellets, the su-
pernatants were analyzed in 96-well plates for total protein concen-
tration using the Bradford solution (Bio-Rad, Munich, Germany) 
and bovine serum albumin (BSA) as the standard in at least tripli-
cates. Total protein (10-20 µg) was diluted in sample buffer (0.3 M 
Tris/HCl, pH 7, 50% glycerol, 5% SDS, 1 mM EDTA, 0.1% brom-
phenol blue), and subjected to SDS–PAGE using the Novex mini-
cell (Invitrogen, Carlsbad, CA, USA) with precast 4–20% Precise 
gels (Pierce–Thermo Fisher). Protein was transferred to poly-
vinylidene difluoride membranes (Schleicher & Schuell, Germany) 
following the manufacturer's instructions. Membranes blocked with 
5% nonfat milk powder and 1% BSA in Tris-buffer saline contain-
ing 0.05% Tween 20 were incubated with specific primary antibod-
ies at 4 °C overnight. Antigen-antibody complexes were stained 
using horseradish peroxidase (HRP)-coupled anti-rabbit antibody 
(Bio-Rad, Richmond CA, USA). Enhanced chemiluminescence was 
recorded using a gel documentation system from Intas (Göttingen, 
Germany). A specific sandwich ELISA technique allowed quantify-
ing glutaredoxin-2 level as described by Lundberg et al. (2004) and 
Hanschmann et al. (2010). The source and generation of the anti-
bodies used in this study are described by Godoy et al. (2011). 
2.4. Immunohistochemistry 
 Immunohistochemistry analysis was performed as described by 
Aon-Bertolino et al. (2011) and Godoy et al. (2011) with slight 
modifications. Animals were anesthetized with 0.1 mL of a 28% 
w/v chloral hydrate solution/100 g body weight, and intracardially 
perfused with 4% paraformaldehyde (Sigma-Aldrich, St. Louis, 
MO, USA) freshly prepared in phosphate buffer 0.1 M, pH 7.4. 
Following brain dissection and a 2-h fixation in 4% paraformalde-
hyde solution, coronal sections (40 µm thick) cut on an Oxford 
vibratome for light microscopy were incubated with 3% hydrogen 
peroxide for 10 min to quench endogenous peroxidases. After a 3-
step PBS washing, nonspecific antibody binding sites were blocked 
with 10% normal goat serum (Invitrogen Corporation, Camarillo, 
CA, USA) in PBS, and sections were incubated overnight with the 
primary antibodies at 4 °C. After the 3-step PBS washing and room 
temperature incubation with a biotinylated secondary antibody 
(Vector Laboratories Inc., Burlingame, CA, USA) for 60 min, the 
Extravidin-Peroxidase detection system (Sigma-Aldrich, St. Louis, 
MO, USA) was used for antigen staining following the manufac-
turer's recommendations. Sections were incubated at room tempera-
ture with the substrate Diaminobenzidine (Sigma-Aldrich, St. 
Louis, MO, USA) for 5 min, mounted with Canada balsam (Sigma-
Aldrich, St. Louis, MO, USA), and were examined by light micros-
copy using a Leitz Laborlux S microscope (Heidelberg, Germany) 
equipped with a CCD video camera (Canon). Images were analyzed 
and compiled using Adobe Photoshop 11.0 CS4. 
2.5. Statistical Analysis 
 Western-blot bands intensity was quantified using Gel-Pro® 
Analyzer 3.1 and expressed as the percentage of that observed in 
sham-operated rats. Results were expressed as the mean ± SEM of 
at least four independent determinations of 6 sham-operated or 8 
CCA-ligation rats. Between-group differences in biochemical pa-
rameters and protein levels were analyzed using the two-tailed Stu-
dent's t-test. The level of significance was conventionally set at 5 
%. All analyses were performed using SPSS 15.0 (Chicago, IL, 
USA). 
3. RESULTS 
3.1. Changes in Protein Expression Following Ischemia-
Reperfusion 
 Figs. (1) and (6) illustrate the expression pattern of the fourteen 
Trx family proteins in the cerebellum, corpus striatum, and hippo-
campus. 
 Thirty-day-old rats with CCA ligation showed an increase in 
Prx2 and Trx1 in the cerebellum and corpus striatum, respectively 
(Fig. 2a). Rats with CCA ligation 60 days old showed decreased 
expression of Prx2 and Grx5 in the cerebellum, and also in the cor-
pus striatum for the former (Fig. 2b). The expression of Trx2 and 
Grx2 increased in the hippocampus and the latter in the cerebellum 
as well (Figure 2 b). On post-natal day 90, the Grx5 protein level 
increased in the cerebellum, and Prx2 and TrxR1 expressions de-
creased in the hippocampus and corpus striatum, respectively (Fig. 
2c). 
3.2. Distribution of the Trx family and related proteins in the 
cerebellum, hippocampus and corpus striatum 
 In agreement with western blot analyses, Trx1 staining in-
creased in cellular bodies of the dorsal striatum (Fig. 3a) and the 
CA1 region of the hippocampus in 30-day old rats with CCA liga-
tion (Fig. 4b) and conversely decreased in the axons of the CA1 
pyramidal cells as compared with the sham-operated group. Both 
rat groups showed Prx2 cytosolic distribution in the cerebellum 
with increased immunoreactivity in the axonal projections of Purk-
inje cells in 30-day old rats with CCA ligation (Fig. 3c). 
 Sixty-day-old rats with CCA ligation showed a higher number 
of Grx2-immunostained cellular bodies in both the hippocampus 
and cerebellum (Figs. 4a and 4b).  Similarly, a higher number of 
Trx2-positive cellular bodies (Fig. 4c) and potential astrocytes (Fig. 
4c, insert) were observed in the hippocampus in 60-day old rats 
with CCA ligation as compared with sham-operated rats. While all 
60-day-old rats showed sustained Prx2 cytosolic distribution, Prx2 
immunoreactivity decreased in the corpus striatum and cerebellum 
in rats with CCA ligation as compared with the sham-operated 
group (Figs. 4d and 4e). 
 Notwithstanding the increase in nuclear Prx2 immunostaining 
found in 90-day-old rats with CCA ligation (Fig. 5a), a decrease 
was observed in the CA1 area of the hippocampus as compared 
with their sham-operated counterparts.  Similarly, nuclear Grx5 
immunostaining increased in the cerebellum Purkinje layer in 90-
day-old rats with CCA ligation (Fig. 5b). At the same time, TrxR1 
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Fig. (1). Expression of thioredoxins and related proteins in CCA-ligation rats (n=8) and sham-operated (n=6) rats. 
The hippocampus (hip), corpus striatum (str), and cerebellum (cer) were isolated and analyzed for protein expression using Western blot, or a specific sandwich 
ELISA for Grx2. The diagram depicts protein expression as the relative percentage of that observed in sham-operated rats. Values represent the mean ± SEM. 
*p ≤ 0.05. (A higher resolution / colour version of this figure is available in the electronic copy of the article). 
4    Current Pharmaceutical Design, 2019, Vol. 25, No. 00 Otero-Losada et al. 
 
Fig. (2). Distinctive expression pattern of specific redoxins in CCA-ligation rats (n=8) and control sham-operated rats (n=6) overtime after the ischemic insult. 
(b) striatum (left) and cerebellum (right) at 30 days of age; (c) striatum (left), hippocampus (middle) and cerebellum (right) at 60 days of age; (d) striatum (left), 
hippocampus (middle) and cerebellum (right) at 90 days of age. Protein expression is shown as the relative percentage to that observed in sham-operated rats. 
Representative Western blots are also illustrated. Values represent the mean ± SEM of 5 independent determinations at least. * p ≤ 0.05. (A higher resolution / 
colour version of this figure is available in the electronic copy of the article). 
 
 
Fig. (3). Immunohistochemical analysis of the expression pattern of the thioredoxins family of proteins in sham-operated (n=6) and CCA-ligation (n=6) 30-day 
old rats. 
a) Trx1 representative pictures of dorsal striatum: arrowheads show an increase in the number of immunopositive positive cellular bodies; b) Trx1 representa-
tive pictures of the CA1 area of the hippocampus: arrowheads show the change in immunopositive cellular bodies in CCA-ligation rats, whereas arrows show 
the large increase in immunopositive pyramidal cells projections in sham-operated rats; c) Prx2 representative pictures of the cerebellum: disruption of the 
Purkinje cell layer is observed in the CCA-ligation group (bottom panel), arrowheads show a large increase in immunopositive axonal projections of Purkinje 
cells in CCA-ligation rats. Scale bar: 50 µm. (A higher resolution / colour version of this figure is available in the electronic copy of the article). 
Hypoxia-Reoxygenation on Rat Brain Thioredoxins Current Pharmaceutical Design, 2019, Vol. 25, No. 00    5 
 
Fig. (4). Immunohistochemical analysis of thioredoxins expression in sham-operated (n=6) and CCA-ligation (n=6) rats 60 days after the ischemic insult. 
a) Grx2 immunostaining in the CA1 area of the hippocampus: arrowheads indicate an increased number of immunopositive cellular bodies in CCA-ligation 
rats; b) Grx2 localization in the cerebellum: arrowheads show an increased number of immunopositive cellular bodies and Purkinje cell layer is disrupted in 
CCA-ligation rats; c) Trx2 expression pattern in the CA1 area of the hippocampus: arrowheads show an increased number of immunopositive cellular bodies in 
CCA-ligation rats, which bear a strong immunoreactivity in what appear to be astrocytes (Insert); d) Prx2 representative pictures in the striatum: cytosolic dis-
tribution is observed in both rat groups; e) Prx2 localization in the cerebellum: immunopositivity is decreased in the granular layer in CCA-ligation rat. Scale 
bar: 50 µm. (A higher resolution / colour version of this figure is available in the electronic copy of the article). 
 
 
Fig. (5). Immunohistochemical analysis of the expression pattern of thioredoxin family of proteins in sham-operated (n=6) and CCA-ligation (n=6) rats 90 days 
after the ischemic insult. 
a) Prx2 representative pictures from CA1 area of the hippocampus: arrowheads show an increased number of immunopositive cellular bodies in the CCA-
ligation group regardless of the overall immunostaining decrease; b) Grx5 representative pictures from the cerebellum: arrowheads show an increase in nuclear 
staining in the Purkinje cell layer in CCA-ligation rats; c) TrxR1 representative pictures from the striatum: arrowheads show an increase in immunopositive 
cellular bodies in the sham-operated group. Scale bar: 50 µm. 
Bar diagrams depict the mean of at least four independent measures in sham-operated (n = 6) and CCA-ligation (n = 8) animals ± SEM. (A higher resolution / 
colour version of this figure is available in the electronic copy of the article). 
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Fig. (6). Differential expression of thioredoxins in the brain of CCA-ligation rats. (A higher resolution / colour version of this figure is available in the elec-
tronic copy of the article). 
 
nuclear immunostaining decreased in the dorsal striatum in 90-day-
old rats with CCA ligation (Fig. 5c). 
4. DISCUSSION 
 Reperfusion following an ischemic event boosts free radicals 
production with ensuing oxidative stress [18, 19], which has been 
consistently presumed as an important cause of ische-
mia/reperfusion-induced neuronal death [11, 19-21]. 
 Previously, we reported the complex expression pattern of thi-
oredoxins and related proteins in the rat central nervous system 
(CNS) [22]. It confirmed tissue- and cell type-specific distribution 
of these proteins, as an expression of specific functions and family 
members´ complex crosstalk (Fig 6). 
 Presently, we examined the expression and distribution of 14 
proteins of the thioredoxin family in a murine model of perinatal 
asphyxia aiming to analyze and understand their specific role in the 
immediate and long-term effects triggered by a hypoxic insult. We 
observed complex tissue-specific changes in the expression and 
distribution of distinct proteins following oxygen deprivation. In-
terestingly, the analyzed proteins seemed differently affected, de-
pending on the time elapsed after the hypoxic insult. Although there 
are no available reports on Trx family proteins in perinatal as-
phyxia, both NO (nitric oxide) and ROS release has been implicated 
in this condition [11], potentially leading to redox signaling dys-
regulation, which might be responsible for inducing apoptosis in the 
CNS and long-term neurological deficits. Much like perinatal as-
phyxia pathology, redox control disruption or overall ROS genera-
tion [13, 14] by mitochondrial chain uncoupling [23] and inflamma-
tion [24, 25] were described as the key destructive downstream 
mechanisms underlying ischemia/reperfusion injury. 
 Our study shows sustained Trx1 expression as late as 30 days 
after ischemia/reperfusion (Fig. 1). Notwithstanding severe hypoxia 
effects on cytosolic antioxidant Trx1 expression in the brain have 
been shown in preconditioned rats 24 h and 72 h after reperfusion 
[17, 26, 27], no study has been conducted on CNS long-term altera-
tions. The increased expression of Grx2 lasts for as long as 60 days 
after ischemia/reperfusion in the CCA ligated rats (Fig. 1). Oxi-
doreductase expression induction was also observed in a renal 
ischemia/reperfusion injury model [28]. Glutaredoxin 2 was overly 
expressed in proximal tubule cells, which can recover after an 
ischemic insult. Hypoxia-reoxygenation exposed HEK293, and 
HeLa cells overexpressing Grx2 showed less oxidative damage and 
increased survival and proliferation rates as compared with the 
wild-type counterparts [28]. All in all, the Grx2 over-expression 
might represent the system's attempt to recovering from the hy-
poxic-ischemic insult. As well as the anti-apoptotic effect of ROS-
inducing drugs such as doxorubicin [17, 29], Grx2 has been re-
cently proved essential for embryonic brain development [30]. Oxi-
doreductase-silenced Zebrafish typically showed overall neuronal 
loss due to apoptosis and lack of a developed axonal scaffold [30]. 
The findings suggest that these proteins could be involved in long-
term regeneration of physiological redox signaling with the recov-
ery of affected tissues. 
 Carotid artery ligation reduced Prx2 expression in rats 60 and 
90 days old. Peroxiredoxin 2 exhibited potent pro-survival effects 
in ischemic neurons by keeping Trx reduced [31]. Thereby, this 
reduction could be an effect of the depletion of the protein while 
maintaining the high levels of trx1 expression. 
 The Trx family of proteins has been reported as contributing to 
early brain tolerance after stress exposure [27, 32]. Here we report 
brain protection as long as 90 days after the insult. These changes 
presumably contributed to an adaptive response to the adverse con-
ditions. 
 The superior brainstem, cerebellum, white matter and subcorti-
cal structures supplied by the distal branches of deep and superficial 
penetrating blood vessels, cerebral white matter between the major 
cerebral artery territories, the CA1 region of the hippocampus, and 
neocortical layers 3, 5, and 6 are some of the most hypoxia-
ischemia vulnerable brain areas [33-35]. The modified pattern of 
the Trx family protein expression found in the most vulnerable 
areas of the brain, particularly in the hippocampus and cerebellum 
endorses the idea of the therapeutic use of these proteins to counter-
act brain damage following an ischemia/reperfusion insult. Not-
withstanding the beneficial effects of Trx administration in adult 
stroke models [36, 37] and the implication of several Trx family 
members in cell survival, proliferation, and regeneration processes 
[38, 39], to our knowledge, thioredoxins have not been so far tested 
in a neonatal model of asphyxia. 
CONCLUSION 
 Present findings suggest that the Trx family of proteins might 
contribute to long-term survival and recovery supporting their 
therapeutic use to curtail ischemic brain oxidative damage follow-
ing an ischemia/reperfusion insult. Characterization of ische-
mia/reperfusion oxidative brain damage and analysis of the in-
volved mechanisms are required to understand the underneath proc-
esses triggered by ischemia/reperfusion and to what extent and in 
what way thioredoxins contribute to recovery from brain hypoxic 
stress. 
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